TY - JOUR AU - Lowy, F. D. PY - 1998 DA - 1998// TI - Staphylococcus aureus infections JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199808203390806 DO - 10.1056/NEJM199808203390806 ID - Lowy1998 ER - TY - JOUR AU - Dantes, R. AU - Mu, Y. AU - Belflower, R. AU - Aragon, D. AU - Dumyati, G. AU - Harrison, L. H. PY - 2013 DA - 2013// TI - National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011 JO - JAMA Intern Med VL - 173 ID - Dantes2013 ER - TY - JOUR AU - Wang, J. T. AU - Lauderdale, T. L. AU - Lee, W. S. AU - Huang, J. H. AU - Wang, T. H. AU - Chang, S. C. PY - 2010 DA - 2010// TI - Impact of active surveillance and contact isolation on transmission of methicillin-resistant Staphylococcus aureus in intensive care units in an area with high prevalence JO - J Formos Med Assoc VL - 109 UR - https://doi.org/10.1016/S0929-6646(10)60051-4 DO - 10.1016/S0929-6646(10)60051-4 ID - Wang2010 ER - TY - JOUR AU - Stefani, S. AU - Goglio, A. PY - 2010 DA - 2010// TI - Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance JO - Int J Infect Dis VL - 14 UR - https://doi.org/10.1016/j.ijid.2010.05.009 DO - 10.1016/j.ijid.2010.05.009 ID - Stefani2010 ER - TY - JOUR AU - Liu, C. AU - Bayer, A. AU - Cosgrove, S. E. AU - Daum, R. S. AU - Fridkin, S. K. AU - Gorwitz, R. J. PY - 2011 DA - 2011// TI - Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children JO - Clin Infect Dis VL - 52 UR - https://doi.org/10.1093/cid/ciq146 DO - 10.1093/cid/ciq146 ID - Liu2011 ER - TY - JOUR AU - Davis, J. S. AU - Hal, S. AU - Tong, S. Y. PY - 2015 DA - 2015// TI - Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections JO - Semin Respir Crit Care Med VL - 36 UR - https://doi.org/10.1055/s-0034-1396906 DO - 10.1055/s-0034-1396906 ID - Davis2015 ER - TY - JOUR AU - Chen, Y. S. PY - 2013 DA - 2013// TI - Guidelines for the treatment of methicillin-resistant Staphylococcus aureus infectionsin Taiwan JO - J Microbiol Immunol Infect VL - 46 UR - https://doi.org/10.1016/j.jmii.2013.04.010 DO - 10.1016/j.jmii.2013.04.010 ID - Chen2013 ER - TY - JOUR AU - García, A. B. AU - Candel, F. J. AU - Lopez, L. AU - Chiarella, F. AU - Viñuela-Prieto, J. M. PY - 2016 DA - 2016// TI - In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus JO - J Med Microbiol VL - 65 UR - https://doi.org/10.1099/jmm.0.000341 DO - 10.1099/jmm.0.000341 ID - García2016 ER - TY - JOUR AU - Bayer, A. S. AU - Schneider, T. AU - Sahl, H. G. PY - 2013 DA - 2013// TI - Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall JO - Ann N Y Acad Sci VL - 1277 UR - https://doi.org/10.1111/j.1749-6632.2012.06819.x DO - 10.1111/j.1749-6632.2012.06819.x ID - Bayer2013 ER - TY - JOUR AU - Moore, C. L. AU - Osaki-Kiyan, P. AU - Haque, N. Z. AU - Perri, M. B. AU - Donabedian, S. AU - Zervos, M. J. PY - 2012 DA - 2012// TI - Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study JO - Clin Infect Dis VL - 54 UR - https://doi.org/10.1093/cid/cir764 DO - 10.1093/cid/cir764 ID - Moore2012 ER - TY - JOUR AU - Gonzalez-Ruiz, A. AU - Seaton, R. A. AU - Hamed, K. PY - 2016 DA - 2016// TI - Daptomycin: an evidence-based review of its role in the treatment of gram-positive infections JO - Infect Drug Resist VL - 15 ID - Gonzalez-Ruiz2016 ER - TY - JOUR AU - Soon, R. L. AU - Turner, S. J. AU - Forrest, A. AU - Tsuji, B. T. AU - Brown, J. PY - 2013 DA - 2013// TI - Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureus JO - Int J Antimicrob Agents VL - 42 UR - https://doi.org/10.1016/j.ijantimicag.2013.02.009 DO - 10.1016/j.ijantimicag.2013.02.009 ID - Soon2013 ER - TY - JOUR AU - Snydman, D. R. AU - McDermott, L. A. AU - Jacobus, N. V. PY - 2005 DA - 2005// TI - Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and enterococci by FIC index and timed-kill curves JO - J Chemother VL - 17 UR - https://doi.org/10.1179/joc.2005.17.6.614 DO - 10.1179/joc.2005.17.6.614 ID - Snydman2005 ER - TY - JOUR AU - Rose, W. E. AU - Berti, A. D. AU - Hatch, J. B. AU - Maki, D. G. PY - 2013 DA - 2013// TI - Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infections JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00325-12 DO - 10.1128/AAC.00325-12 ID - Rose2013 ER - TY - JOUR AU - Aktas, G. AU - Derbentli, S. PY - 2017 DA - 2017// TI - In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains JO - J Glob Antimicrob Resist. VL - 10 UR - https://doi.org/10.1016/j.jgar.2017.05.022 DO - 10.1016/j.jgar.2017.05.022 ID - Aktas2017 ER - TY - BOOK PY - 2018 DA - 2018// TI - Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth informational supplement M100-S20 PB - CLSI CY - Wayne ID - ref16 ER - TY - CHAP AU - Pillai, S. K. AU - Moellering, R. C. AU - Eliopoulos, G. M. ED - Lorian, V. PY - 2005 DA - 2005// TI - Antimicrobial combinations BT - Antibiotics in laboratory medicine PB - Lippincott Williams and Wilkins CY - Philadelphia ID - Pillai2005 ER - TY - JOUR AU - Ruiz, J. AU - Ramirez, P. AU - Concha, P. AU - Salavert-Lletí, M. AU - Villarreal, E. AU - Gordon, M. PY - 2018 DA - 2018// TI - Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia JO - J Glob Antimicrob Resist VL - 14 UR - https://doi.org/10.1016/j.jgar.2018.03.007 DO - 10.1016/j.jgar.2018.03.007 ID - Ruiz2018 ER - TY - JOUR AU - Hendlin, D. AU - Stapley, E. O. AU - Jackson, M. AU - Wallick, H. AU - Miller, A. K. AU - Wolf, F. J. PY - 1969 DA - 1969// TI - Phosphonomycin, a new antibiotic produced by strains of streptomyces JO - Science. VL - 166 UR - https://doi.org/10.1126/science.166.3901.122 DO - 10.1126/science.166.3901.122 ID - Hendlin1969 ER - TY - JOUR AU - Falagas, M. E. AU - Roussos, N. AU - Gkegkes, I. D. AU - Rafailidis, P. I. AU - Karageorgopoulos, D. E. PY - 2009 DA - 2009// TI - Fosfomycin for the treatment of infections caused by gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies JO - Expert Opin Investig Drugs VL - 18 UR - https://doi.org/10.1517/13543780902967624 DO - 10.1517/13543780902967624 ID - Falagas2009 ER - TY - JOUR AU - Debbia, E. AU - Pesce, A. AU - Schito, G. C. PY - 1988 DA - 1988// TI - In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria JO - Antimicrob Agents Chemother VL - 32 UR - https://doi.org/10.1128/AAC.32.2.279 DO - 10.1128/AAC.32.2.279 ID - Debbia1988 ER - TY - JOUR AU - Lingscheid, T. AU - Poeppl, W. AU - Bernitzky, D. AU - Veletzky, L. AU - Kussmann, M. AU - Plasenzotti, R. PY - 2015 DA - 2015// TI - Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.04246-14 DO - 10.1128/AAC.04246-14 ID - Lingscheid2015 ER - TY - JOUR AU - Miró, J. M. AU - Entenza, J. M. AU - Río, A. AU - Velasco, M. AU - Castañeda, X. AU - Garcia de la Mària, C. PY - 2012 DA - 2012// TI - High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.06449-11 DO - 10.1128/AAC.06449-11 ID - Miró2012 ER - TY - JOUR AU - Popovic, M. AU - Steinort, D. AU - Pillai, S. AU - Joukhadar, C. PY - 2010 DA - 2010// TI - Fosfomycin: an old, new friend? JO - Eur J Clin Microbiol Infect Dis VL - 29 UR - https://doi.org/10.1007/s10096-009-0833-2 DO - 10.1007/s10096-009-0833-2 ID - Popovic2010 ER - TY - JOUR AU - MacGowan, A. P. PY - 2003 DA - 2003// TI - Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with gram-positive infections JO - J Antimicrob Chemother VL - 51 ID - MacGowan2003 ER - TY - JOUR AU - Jang, H. C. AU - Kim, S. H. AU - Kim, K. H. AU - Kim, C. J. AU - Lee, S. AU - Song, K. H. PY - 2009 DA - 2009// TI - Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem JO - Clin Infect Dis VL - 49 UR - https://doi.org/10.1086/600295 DO - 10.1086/600295 ID - Jang2009 ER - TY - JOUR AU - Parra-Ruiz, J. AU - Bravo-Molina, A. AU - Peña-Monje, A. AU - Hernández-Quero, J. PY - 2012 DA - 2012// TI - Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm JO - J Antimicrob Chemother VL - 67 UR - https://doi.org/10.1093/jac/dks272 DO - 10.1093/jac/dks272 ID - Parra-Ruiz2012 ER - TY - JOUR AU - Steed, M. E. AU - Vidaillac, C. AU - Rybak, M. J. PY - 2010 DA - 2010// TI - Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00536-10 DO - 10.1128/AAC.00536-10 ID - Steed2010 ER - TY - JOUR AU - Kelesidis, T. AU - Humphries, R. AU - Ward, K. AU - Lewinski, M. A. AU - Yang, O. O. PY - 2011 DA - 2011// TI - Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia JO - Diagn Microbiol Infect Dis VL - 71 UR - https://doi.org/10.1016/j.diagmicrobio.2011.07.001 DO - 10.1016/j.diagmicrobio.2011.07.001 ID - Kelesidis2011 ER - TY - JOUR AU - Leonard, S. N. AU - Rolek, K. M. PY - 2013 DA - 2013// TI - Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus JO - J Antimicrob Chemother VL - 68 UR - https://doi.org/10.1093/jac/dks453 DO - 10.1093/jac/dks453 ID - Leonard2013 ER - TY - JOUR AU - Garrigós, C. AU - Murillo, O. AU - Lora-Tamayo, J. AU - Verdaguer, R. AU - Tubau, F. AU - Cabellos, C. PY - 2012 DA - 2012// TI - Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 56 UR - https://doi.org/10.1128/AAC.00127-12 DO - 10.1128/AAC.00127-12 ID - Garrigós2012 ER - TY - JOUR AU - Dhand, A. AU - Bayer, A. S. AU - Pogliano, J. AU - Yang, S. J. AU - Bolaris, M. AU - Nizet, V. PY - 2011 DA - 2011// TI - Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir340 DO - 10.1093/cid/cir340 ID - Dhand2011 ER - TY - JOUR AU - Sakoulas, G. AU - Okumura, C. Y. AU - Thienphrapa, W. AU - Olson, J. AU - Nonejuie, P. AU - Dam, Q. PY - 2014 DA - 2014// TI - Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus JO - J Mol Med (Berl) VL - 92 UR - https://doi.org/10.1007/s00109-013-1100-7 DO - 10.1007/s00109-013-1100-7 ID - Sakoulas2014 ER - TY - JOUR AU - Credito, K. AU - Lin, G. AU - Appelbaum, P. C. PY - 2007 DA - 2007// TI - Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.01455-06 DO - 10.1128/AAC.01455-06 ID - Credito2007 ER - TY - JOUR AU - LaPlante, K. L. AU - Woodmansee, S. PY - 2009 DA - 2009// TI - Activities of daptomycin and vancomycin alone and in combinationwith rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.00134-09 DO - 10.1128/AAC.00134-09 ID - LaPlante2009 ER - TY - JOUR AU - Rose, W. E. AU - Leonard, S. N. AU - Rybak, M. J. PY - 2008 DA - 2008// TI - Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations JO - Antimicrob Agents Chemother VL - 52 UR - https://doi.org/10.1128/AAC.00102-08 DO - 10.1128/AAC.00102-08 ID - Rose2008 ER - TY - JOUR AU - Perlroth, J. AU - Kuo, M. AU - Tan, J. AU - Bayer, A. S. AU - Miller, L. G. PY - 2008 DA - 2008// TI - Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.8.805 DO - 10.1001/archinte.168.8.805 ID - Perlroth2008 ER - TY - JOUR AU - Raad, I. AU - Hanna, H. AU - Jiang, Y. AU - Dvorak, T. AU - Reitzel, R. AU - Chaiban, G. PY - 2007 DA - 2007// TI - Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.00350-06 DO - 10.1128/AAC.00350-06 ID - Raad2007 ER - TY - JOUR AU - Saleh-Mghir, A. AU - Muller-Serieys, C. AU - Dinh, A. AU - Massias, L. AU - Crémieux, A. C. PY - 2011 DA - 2011// TI - Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.00675-11 DO - 10.1128/AAC.00675-11 ID - Saleh-Mghir2011 ER - TY - JOUR AU - Lora-Tamayo, J. AU - Parra-Ruiz, J. AU - Rodríguez-Pardo, D. AU - Barberán, J. AU - Ribera, A. AU - Tornero, E. PY - 2014 DA - 2014// TI - High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study JO - Diagn Microbiol Infect Dis VL - 80 UR - https://doi.org/10.1016/j.diagmicrobio.2014.05.022 DO - 10.1016/j.diagmicrobio.2014.05.022 ID - Lora-Tamayo2014 ER - TY - JOUR AU - Hagiya, H. AU - Terasaka, T. AU - Kimura, K. AU - Satou, A. AU - Asano, K. AU - Waseda, K. PY - 2014 DA - 2014// TI - Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin JO - Intern Med VL - 53 UR - https://doi.org/10.2169/internalmedicine.53.2711 DO - 10.2169/internalmedicine.53.2711 ID - Hagiya2014 ER -